Revisiting the cardiovascular risk of hydroxychloroquine in RA - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Nature Reviews Rheumatology Année : 2020

Revisiting the cardiovascular risk of hydroxychloroquine in RA

Résumé

Cardiac toxicity can be induced by hydroxychloroquine, especially when used in combination with azithromycin. Interest in hydroxychloroquine and azithromycin as potential therapies for COVID-19 has renewed concerns about the possible cardiovascular risk these drugs present to patients with rheumatoid arthritis.

Dates et versions

hal-03338004 , version 1 (08-09-2021)

Identifiants

Citer

Yves-Marie Pers, Guillaume Padern. Revisiting the cardiovascular risk of hydroxychloroquine in RA. Nature Reviews Rheumatology, 2020, 16 (12), pp.671-672. ⟨10.1038/s41584-020-00521-x⟩. ⟨hal-03338004⟩
20 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More